ReviewJournal of intensive medicine2022

The effect of renin-angiotensin-aldosterone system inhibitors in patients with hypertension and COVID-19: A meta-analysis of randomized controlled trials and propensity score-matched studies.

Kai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.